This study is an open-label study. It has two stages. Stage 1 is a dose escalation phase of the study to determine and evaluate the safety and tolerability of repeated treatments with a genetically en
This phase III trial is studying how well radiation therapy, amifostine, and chemotherapy work in treating young patients with newly diagnosed nasopharyngeal cancer. Radiation therapy uses high-ener
Abbreviations: OS = overall survival, PFS = progression-free survival, ECOG PS = Eastern Cooperative Oncology Group performance status.*indicating the median score of proportion of good ECOG-PS patien
